
亚太地区 GMP 测试服务市场预测至 2028 年 – COVID-19 影响和区域分析 – 按服务类型(产品验证测试、生物分析服务、包装和保质期测试以及其他服务类型)和最终用户(制药和生物制药公司、医疗器械公司)
No. of Pages: 116 | Report Code: BMIRE00027756 | Category: Life Sciences
No. of Pages: 116 | Report Code: BMIRE00027756 | Category: Life Sciences
亚太地区GMP检测服务市场预计将从2022年的3.3972亿美元增长到2028年的5.1579亿美元;预计 2022 年至 2028 年复合年增长率为 7.2%。
制药行业的持续生产有助于市场增长
药品和其他医药产品的研究、开发、生产和分销是制药行业的主要领域。 Torreya 的一篇文章称,2017 年药品支出总额为 10,420 亿美元,预计到 2030 年将达到 16,710 亿美元。该人群人口的增加是导致药品支出激增的主要原因慢性疾病的患病率,例如心血管疾病、癌症、高血压、骨关节炎和糖尿病。因此,这些慢性疾病一直是制药公司关注的主要领域。新药开发是一个资源、成本和时间密集的过程,其中后期的临床阶段会导致巨大的成本。发现一种药物并获得监管部门的批准需要约 10-15 年的时间,平均成本超过 1-20 亿美元。多家制药公司选择生物分析 GMP 测试服务来进行药物开发以及临床和临床前阶段的检测验证。仿制药和品牌药物化合物大多是小分子。仿制药制造商进行并提交生物分析 GMP 测试结果,以克服专利到期的问题。因此,随着制药行业的蓬勃发展,药品开发中GMP测试的实施正在推动亚太地区GMP测试服务市场的增长。
亚太地区GMP 测试服务市场概览
亚太地区 (APAC) 是 GMP 测试服务增长最快的区域市场。亚太地区 GMP 测试服务市场进一步细分为中国、印度、日本、韩国、澳大利亚和亚太其他地区。预测期内中国市场的预计增长归因于制药公司数量及其研发活动的增加等因素。
亚洲太平洋 GMP 测试服务市场收入及预测至 2028 年(百万美元)
亚太区GMP检测服务市场细分
亚太区GMP检测服务市场根据服务类型、最终用户和国家进行细分。根据服务类型,亚太地区 GMP 测试服务市场分为产品验证测试、生物分析服务、包装和检测服务。保质期测试等服务类型。 2022年,产品验证测试领域占据最大市场份额。
根据最终用户,亚太区GMP测试服务市场分为制药和生物制药公司以及医疗器械公司。 2022年,制药和生物制药公司细分市场占据更大的市场份额。
按国家划分,亚太地区GMP检测服务市场分为中国、日本、印度、澳大利亚、韩国以及亚太其他地区。 2022 年,中国在市场份额中占据主导地位。
Eurofins Scientific;阿尔马克集团;天祥集团有限公司;药明康德;赛多利斯公司;北美科学协会;尼尔森实验室有限责任公司;和 Thermo Fisher Scientific Inc. (PPD Inc.) 是亚太 GMP 测试服务市场的领先公司之一。
Strategic insights for Asia Pacific GMP Testing Service involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 339.72 Million |
Market Size by 2028 | US$ 515.79 Million |
Global CAGR (2022 - 2028) | 7.2% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 服务类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific GMP Testing Service refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific GMP Testing Service Market is valued at US$ 339.72 Million in 2022, it is projected to reach US$ 515.79 Million by 2028.
As per our report Asia Pacific GMP Testing Service Market, the market size is valued at US$ 339.72 Million in 2022, projecting it to reach US$ 515.79 Million by 2028. This translates to a CAGR of approximately 7.2% during the forecast period.
The Asia Pacific GMP Testing Service Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific GMP Testing Service Market report:
The Asia Pacific GMP Testing Service Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific GMP Testing Service Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific GMP Testing Service Market value chain can benefit from the information contained in a comprehensive market report.